Zero Sperm Count (Azoospermia): Treatment Options and Chances of Fatherhood

Zero Sperm Count (Azoospermia): Can You Still Be a Father?

Finding no sperm in the ejaculate — azoospermia — is one of the most devastating fertility diagnoses a man can receive. Yet it is not, in most cases, the end of the road for biological fatherhood. Depending on the underlying cause, 40–95% of azoospermic men can have sperm retrieved surgically and used to father children through ICSI. This guide explains everything.

What Is Azoospermia?

Azoospermia means no sperm are found in the ejaculate on semen analysis. It affects approximately 1% of all men and 10–15% of infertile men. There are two fundamentally different types with completely different outlooks and treatments.

Type 1: Obstructive Azoospermia (OA)

What it means: Sperm are produced normally in the testes but cannot exit due to a blockage somewhere in the reproductive tract. The testes feel normal in size and firmness. FSH is typically normal.

Common causes:

• Congenital bilateral absence of the vas deferens (CBAVD): The vas deferens (the tube carrying sperm) is absent from birth — associated with mutations in the CFTR cystic fibrosis gene. Sperm are produced but have nowhere to go. Critical: The female partner must be tested for CFTR carrier status — if both partners carry mutations, children are at risk of cystic fibrosis.
• Prior vasectomy: The most common cause in men who have had a previous vasectomy and now want more children.
• Epididymal obstruction: From prior infection (chlamydia, gonorrhoea), trauma, or congenital narrowing.
• Ejaculatory duct obstruction: Midline prostatic cysts compressing the ejaculatory ducts — sometimes surgically correctable.

Sperm retrieval success rate in OA: >90% — because sperm are being made, just blocked.

Type 2: Non-Obstructive Azoospermia (NOA)

What it means: Sperm production itself is severely impaired or absent. FSH is typically elevated (pituitary working harder to stimulate unresponsive testes). Testes may be smaller and softer than normal.

Common causes:

• Klinefelter syndrome (47,XXY): Most common genetic cause. Extra X chromosome disrupts testicular development. Affects 1 in 650 men — many are not diagnosed until infertility investigation.
• Y-chromosome microdeletions (AZF regions): Missing sections of the Y chromosome containing genes essential for sperm production. AZFa and AZFb deletions typically mean no sperm retrievable; AZFc deletions give approximately 50% micro-TESE success.
• Sertoli-cell-only syndrome (SCO): The testicular tubules contain only Sertoli support cells — no sperm-producing cells (spermatogonia). Approximately 20–30% still have focal areas of sperm production.
• Maturation arrest: Sperm production begins but arrests at an early stage. 40–60% have retrievable mature sperm.
• Prior chemotherapy or radiotherapy: Gonadotoxic treatment can destroy sperm-producing stem cells. Recovery possible in some cases — may take 2–3 years.
• Hormonal causes: Hypogonadotropic hypogonadism — the pituitary is not producing enough FSH/LH to drive sperm production. Often highly treatable with FSH/hCG injections.

Sperm retrieval success rate in NOA: 40–60% with micro-TESE — varies significantly by underlying cause.

Surgical Sperm Retrieval Techniques

For Obstructive Azoospermia:

PESA (Percutaneous Epididymal Sperm Aspiration): A fine needle passed through the scrotal skin into the epididymis. Local or light sedation. Quick (15–30 minutes). Retrieves large numbers of sperm. First-line for OA.

MESA (Microsurgical Epididymal Sperm Aspiration): Open microsurgical access to the epididymis under magnification. More sperm retrieved than PESA — enough to cryopreserve multiple aliquots for future ICSI attempts. Used when PESA yields inadequate sperm.

TESE (Testicular Sperm Extraction): Small incision in the testis to remove small pieces of tissue from which sperm are extracted. Used when epididymal sperm is unavailable (e.g. CBAVD without epididymis).

For Non-Obstructive Azoospermia:

Conventional TESE: Multiple random biopsies of testicular tissue. Retrieval success in NOA: 30–50%. More testicular damage than micro-TESE.

Micro-TESE (Microsurgical TESE): The gold standard for NOA. An operating microscope (25–40× magnification) examines the seminiferous tubules directly. Larger, more opaque tubules — indicating active sperm production — are selectively biopsied while sparing the rest of the testis. This concentrates the biopsy on the most productive areas.

Micro-TESE success rates by cause:

What Happens With Retrieved Sperm

Retrieved sperm are used immediately for ICSI (one sperm injected into each of the partner's eggs) or cryopreserved for future use. Because retrieved quantities are small, ICSI is the only viable fertilisation method.

Live birth rates with ICSI using surgically retrieved sperm:

• OA (PESA/TESE): 40–55% per ICSI transfer — comparable to non-azoospermic men
• NOA (micro-TESE): 25–45% per transfer depending on cause and partner age

Genetic Testing Before Sperm Retrieval

ASRM 2022 strongly recommends before any retrieval:

• Karyotype: Identifies Klinefelter syndrome and other chromosomal causes
• Y-chromosome microdeletion analysis: AZFa and AZFb deletions predict failed retrieval; AZFc deletions may succeed
• CFTR gene testing: For CBAVD patients — partner must also be tested

Why genetic testing matters for offspring: If Y-chromosome microdeletion (AZFc) is present, any male children conceived will inherit the deletion and will likely also be azoospermic. This does not prevent the couple from proceeding but requires genetic counselling and informed consent.

When Donor Sperm Is Considered

Donor sperm is an option when:

• Micro-TESE fails to retrieve any sperm
• Genetic abnormality makes own sperm transmission unacceptable
• Multiple failed retrieval attempts
• The couple chooses not to pursue surgical retrieval

Under the ICMR ART Act 2021, anonymous donor sperm from licensed ART banks is the only legal form of donor sperm in India (known donation to a named donor is not permitted).

Reference: ASRM Practice Committee — Evaluation of the Azoospermic Male, 2022. EAU Guidelines — Male Infertility, 2023.